Fiona Marshall is VP Head of the UK Discovery Centre, MSD Research Laboratories.
She has more than 25 years’ experience in drug discovery and development across Pharma and Biotech companies. Previously Fiona was VP and CSO of the Japanese Biotech company Sosei Group which acquired Heptares Therapeutics in 2015. Fiona was a founder and Chief Scientific Officer of Heptares Therapeutics a highly successful UK Biotech company focussed on structure based drug discovery which was spun out of the MRC LMB in Cambridge.
Fiona is on the council of the Academy of Medical sciences and on advisory boards of the Medical Research Council, the Francis Crick Institute and the Wellcome Trust. She won the 2012 WISE Women of Outstanding Achievement for Innovation and Entrepreneurship and the 2015 RSC Malcolm Campbell Award for chemistry. She is a Fellow of the British Pharmacological Society and the Academy of Medical Sciences.
Fiona is renowned for her work on G protein-coupled receptors (GPCRs) and has published extensively in the field. She has a BSc in biochemistry from Bath University and a PhD in neuroscience from Cambridge University.